Niagen Bioscience (NAGE) Tax Provisions (2016 - 2026)
Niagen Bioscience (NAGE) reported Tax Provisions of $417000.0 for Q1 2026, up 148.21% year-over-year from $168000.0 in Q1 2025, and up 42.81% quarter-over-quarter from $292000.0 in Q4 2025.
Niagen Bioscience (NAGE) Tax Provisions (2016 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 4 years of Tax Provisions data on file, last reported at $417000.0 in Q1 2026.
- Tax Provisions for Q1 2026 came in at $417000.0, up 148.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 123.89% YoY), and the FY2025 annual result was $810000.0, up 165.57% from the prior year.
- Tax Provisions climbed to $417000.0 in Q1 2026 per NAGE's latest filing, from $292000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $417000.0 in Q1 2026 and troughed at $128000.0 in Q2 2025.
- A 3-year average of $255333.3 and a median of $257000.0 in 2025 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2025 and 2026: Tax Provisions retreated 4.26% in 2025, then surged 148.21% in 2026.
- A 3-year view of Tax Provisions shows it stood at $305000.0 in 2024, then dropped by 4.26% to $292000.0 in 2025, then jumped by 42.81% to $417000.0 in 2026.
- Business Quant data shows NAGE's Tax Provisions at $417000.0 in Q1 2026, $292000.0 in Q4 2025, and $222000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Niagen Bioscience | 269.32 Mn | 202.77 Mn | 19.98 Mn | 417,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 417,000.00 |
| Dec 31, 2025 | 292,000.00 |
| Sep 30, 2025 | 222,000.00 |
| Jun 30, 2025 | 128,000.00 |
| Mar 31, 2025 | 168,000.00 |
| Dec 31, 2024 | 305,000.00 |
| Dec 31, 2016 | 3,500.00 |
| Oct 1, 2016 | 3,153.00 |
| Jul 2, 2016 | 4,087.00 |
| Apr 2, 2016 | -10,740.00 |
| Jan 2, 2016 | 4,527.00 |